Table 2 Characteristics of RP and BT patients after PSM
RP (n = 96) | BT (n = 96) | P value | |
|---|---|---|---|
Age(years) | 77.00 (74.00–80.00) | 77.00 (72.00–80.00) | 0.988 |
tPSA(ng/ml) | 10.68 (6.95–21.42) | 11.91 (6.93–25.58) | 0.399 |
Gleason score(%) | 0.668 | ||
6 | 29 (30.2%) | 20 (20.8%) | |
7 | 22 (22.9%) | 32 (33.3%) | |
8 | 25 (26.0%) | 27 (28.1%) | |
9 | 19 (19.8%) | 14 (14.6%) | |
10 | 1 (1.0%) | 3 (3.1%) | |
PPB | 0.40 (0.22–0.61) | 0.44 (0.24–0.67) | 0.117 |
Clinical T stage (%) | 0.637 | ||
T1 | 4 (4.2%) | 4 (4.2%) | |
T2 | 70 (72.9%) | 73 (76.0%) | |
T3 | 22 (2.9%) | 19 (19.8%) | |
Charlson score (%) | 0.601 | ||
0 | 65 (67.7%) | 62 (64.6%) | |
1 | 24 (25.0%) | 25 (26.0%) | |
2 | 6 (6.3%) | 7 (7.3%) | |
3 | 1 (1.0%) | 1 (1.0%) | |
4 | 0 | 1 (1.0%) |